Multi-omics Pathway Enrichment Analysis
Also known as: multi-omics pathway analysis, integrated pathway enrichment, multi-layer pathway enrichment, MOPEA
Multi-omics pathway enrichment analysis is a bioinformatics pipeline that integrates molecular data from two or more omics layers — such as transcriptomics, proteomics, metabolomics, and epigenomics — and tests whether the combined signal from those layers converges on specific biological pathways more than expected by chance. By considering multiple molecular levels simultaneously, it identifies pathway-level dysregulation that single-omics analyses would miss.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use multi-omics pathway enrichment when you have collected two or more omics datasets on the same biological samples and your research question is about which biological processes or pathways are jointly dysregulated. It is particularly valuable in disease-mechanism studies, drug-target discovery, and systems biology investigations where single-omics results have been inconclusive or contradictory. The method requires well-matched samples across omics layers (ideally the same individuals or cell lines), at least 6–10 samples per condition for reliable differential statistics, and access to a curated pathway database relevant to your organism. Do not apply it when omics layers come from non-matched samples, when only one omics layer has adequate statistical power, or when the biological question concerns a single molecule rather than a pathway-level process — in those cases, standard single-omics enrichment analysis is more appropriate and less prone to false integration artefacts.
Strengths & limitations
- Increases statistical power to detect pathway-level dysregulation by combining corroborating evidence from multiple molecular layers.
- Reduces the false-positive rate for individual layer analyses by requiring cross-layer replication at the pathway level.
- Provides a biologically interpretable output (pathways and processes) rather than long, disconnected molecule lists.
- Can uncover regulatory mechanisms invisible in any single omics layer, such as post-transcriptional regulation revealed only when mRNA and protein levels diverge.
- Applicable across all organisms for which curated pathway databases (KEGG, Reactome, GO) exist.
- Requires well-matched, high-quality data from multiple omics platforms, making it expensive and logistically demanding to collect.
- Pathway databases are incomplete and biased toward well-studied processes, so novel or under-annotated pathways are systematically missed.
- Results depend heavily on which integration strategy is chosen; different methods (concatenation, meta-analysis, network-based) can yield different pathway rankings for the same data.
- Interpretation is complicated when omics layers provide contradictory signals within the same pathway.
Frequently asked
What is the minimum number of omics layers required?
Two layers are sufficient to apply the method, and two-layer analyses (e.g., transcriptomics plus proteomics) are the most common in practice. Adding a third layer (e.g., metabolomics) increases interpretive depth but also increases data-management complexity and the risk of introducing noise from a poorly powered layer. More layers are only beneficial if each layer has adequate sample size and data quality.
How is this different from running pathway enrichment separately on each omics layer?
Running enrichment on each layer separately produces independent pathway lists that must be manually compared. Multi-omics enrichment formally combines evidence across layers into a single statistical test per pathway, weights contributions by data quality or variance explained, and applies a unified multiple-testing correction. This reduces both false positives (artefacts in one layer) and false negatives (effects too small to reach significance in any single layer).
Which tools implement multi-omics pathway enrichment?
Widely used tools include ActivePathways (R/Bioconductor, based on Fisher's combined p-value), mixOmics with pathway post-processing, MOFA+ followed by gene-set analysis on factor loadings, and iCluster-based pipelines. KEGG and Reactome provide the most commonly used pathway databases. The choice of tool should be driven by the integration design (early, intermediate, or late fusion) and the study's statistical requirements.
Can I apply this method without matched samples across omics layers?
Formal multi-omics integration requires the same samples to be profiled across all layers. If your layers come from different sample sets, you can run single-layer enrichment on each dataset and compare results qualitatively, but this does not constitute multi-omics pathway enrichment in the strict sense and should not be described as such.
How do I handle metabolites, which do not map directly to genes?
Metabolites are typically mapped to genes via metabolic pathway databases (KEGG, MetaCyc, HMDB) that associate each metabolite with the enzyme-coding genes in its biosynthetic or degradation pathway. Some tools also support direct metabolite-set enrichment within KEGG metabolic pathways. When a metabolite lacks a gene mapping, it can be included in topology-aware methods that directly query pathway graph structures.
Sources
- Meng, C., Kuster, B., Culhane, A. C., & Gholami, A. M. (2014). A multivariate approach to the integration of multi-omics datasets. BMC Bioinformatics, 15, 162. link ↗
- Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., & Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545–15550. link ↗
How to cite this page
ScholarGate. (2026, June 3). Multi-omics Pathway Enrichment Analysis. ScholarGate. https://scholargate.app/en/bioinformatics/multi-omics-pathway-enrichment-analysis
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Gene Set Enrichment AnalysisBioinformatics↔ compare